Related Experiment Video

Updated: Aug 5, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Inflammation-Mediated Mechanisms of Arrhythmias After Acute Myocardial Infarction

Huijie Guo1, Jin Liu1, Jinchun Wu2

  • 1School of Clinical Medicine, Qinghai University, 810007 Xining, Qinghai, China.

Reviews in Cardiovascular Medicine
|July 31, 2026
PubMed

Insights

Inflammation drives arrhythmias after acute myocardial infarction (AMI), increasing sudden cardiac death risk. Targeting inflammation may offer new treatments for post-AMI patients.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Pathophysiology

Background:

  • Acute myocardial infarction (AMI) is a primary cause of cardiovascular mortality.
  • Arrhythmias are a frequent complication of AMI, escalating mortality and disease severity.
  • Effective diagnosis and treatment are critical for managing post-AMI complications.

Purpose of the Study:

  • To review the inflammatory mechanisms underlying post-AMI arrhythmias.
  • To explore the role of inflammatory markers in predicting outcomes.
  • To discuss the potential of anti-inflammatory therapies in clinical practice.

Main Methods:

  • Literature review focusing on inflammation's role in post-AMI arrhythmias.
  • Analysis of mechanisms including cellular infiltration, cytokine release, oxidative stress, remodeling, and neuroimmune pathways.
  • Evaluation of predictive inflammatory markers and anti-inflammatory treatment strategies.

Main Results:

  • Inflammation involves key pathways: inflammatory cell infiltration, cytokine release, oxidative stress, cardiac remodeling, and neuroimmune interactions.
  • Specific inflammatory markers show predictive value for arrhythmias and outcomes post-AMI.
  • Anti-inflammatory therapies present promising avenues for clinical intervention.

Conclusions:

  • Understanding inflammation's role is crucial for managing post-AMI arrhythmias.
  • Inflammatory markers can aid in risk stratification and patient management.
  • Targeting inflammation holds potential for novel therapeutic strategies to reduce SCD risk.

Keywords:
acute myocardial infarctionarrhythmiasinflammationsystemic immune–inflammation indexsystemic inflammatory response index

More Related Videos

A Modified Simple Method for Induction of Myocardial Infarction in Mice04:29

A Modified Simple Method for Induction of Myocardial Infarction in Mice

Published on: December 3, 2021

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Inflammation I: Inflammatory Response01:26

Acute Inflammation I: Inflammatory Response

Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...